A highlight of the program is the capstone internship, which allows students to gain the desired work experience. Internship opportunities are available in all the tracks that include research in industry, academic, and government laboratories and in business development, marketing, commercialization, finance, regulatory affairs, and technology transfer.
If this is your first time hearing about the Georgetown Biotechnology Program, our Information Sessions are a great start for you! The goal of the Information Sessions is to give interested students an overview of the Georgetown Biotechnology Program and to engage in an interactive dialogue with our prospective students who are discovering the next generation of biotechnology. We look forward to meeting you virtually and to hearing your questions about the M.S. in Biotechnology. Please stay tuned to find out more about our next Information Sessions.
Georgetown Biotechnology Graduate Student Hour
If you have heard about the Georgetown Biotechnology Program and have been engaged with us during the admission process, Come ‘n Mingle with faculty, alumni, and current students to learn more about our program. We will be hosting the following webinar(s):
Friday, July 8th, 2022 from 12:00 pm to 1:00 pm EST.
If you have a passion for science, health, and biotechnology and would like to explore these subjects in-depth before college, here is your chance to do so with the High School Biotechnology for Science & Health Academy this summer! For more information, visit our website.
Georgetown Biotechnology Launches Two New Courses
The Georgetown Biotechnology Program is thrilled to introduce two new topics to its curriculum: new courses in Vaccine Development and Cell andGene Therapy will cover the most current knowledge and business aspects of their fields. Courses like these will allow our students to become versed in the most cutting-edge technologies and build their skills and expertise towards 21st century needs. Students will learn the scientific, business, and regulatory modalities of vaccine development and gene therapy through these new additions to our program.